NCT05322447View on ClinicalTrials.gov

High-dose L-Carnitine and Diaphragmatic Function Assessed by Ultrasonography in Patients With Respiratory Failure.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

August 4, 2022

Study Completion Date

October 1, 2022

Conditions
Respiratory Failure
Interventions
DRUG

L Carnitine ( low dose)

will receive a maintenance dose of L- carnitine 6 gm/day to keep normal level (normal L-carnitine level is normal 25-50 mmol/L)

DRUG

L-Carnitine ( high dose)

will receive a high dose of L- Carnitine 18 gm/day as a continuous intravenous infusion to reach double the normal plasma level

Trial Locations (2)

1234

Faculty of medicine, Cairo

Unknown

Mona A Ammar, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER